- Home
- AUPH vs BHLB Comparison
AUPH vs BHLB Comparison
Compare AUPH & BHLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- BHLB
- Stock Information
- Founded
- AUPH 1993
- BHLB 1846
- Country
- AUPH Canada
- BHLB United States
- Employees
- AUPH N/A
- BHLB N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- BHLB Banks
- Sector
- AUPH Health Care
- BHLB Finance
- Exchange
- AUPH Nasdaq
- BHLB Nasdaq
- Market Cap
- AUPH 1.1B
- BHLB N/A
- IPO Year
- AUPH 1999
- BHLB 2000
- Fundamental
- Price
- AUPH $8.13
- BHLB $25.97
- Analyst Decision
- AUPH Strong Buy
- BHLB Hold
- Analyst Count
- AUPH 2
- BHLB 5
- Target Price
- AUPH $11.50
- BHLB $32.70
- AVG Volume (30 Days)
- AUPH 1.7M
- BHLB 497.6K
- Earning Date
- AUPH 05-01-2025
- BHLB 04-17-2025
- Dividend Yield
- AUPH N/A
- BHLB 2.80%
- EPS Growth
- AUPH N/A
- BHLB N/A
- EPS
- AUPH 0.04
- BHLB 1.43
- Revenue
- AUPH $235,133,000.00
- BHLB $376,001,000.00
- Revenue This Year
- AUPH $13.80
- BHLB $31.78
- Revenue Next Year
- AUPH $24.57
- BHLB $80.63
- P/E Ratio
- AUPH $203.13
- BHLB $18.10
- Revenue Growth
- AUPH 33.97
- BHLB N/A
- 52 Week Low
- AUPH $4.71
- BHLB $20.50
- 52 Week High
- AUPH $10.67
- BHLB $32.36
- Technical
- Relative Strength Index (RSI)
- AUPH 51.32
- BHLB 27.92
- Support Level
- AUPH $7.92
- BHLB $27.88
- Resistance Level
- AUPH $8.85
- BHLB $28.74
- Average True Range (ATR)
- AUPH 0.42
- BHLB 0.65
- MACD
- AUPH 0.04
- BHLB -0.29
- Stochastic Oscillator
- AUPH 69.72
- BHLB 6.07
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.